In Vivo Imaging of Amyloid Deposition in Alzheimer’s Disease using the Novel Radioligand [(18)F]AV-45 (Florbetapir F 18)

INTRODUCTION: An [(18)F] labeled PET amyloid (Aβ) imaging agent could facilitate clinical evaluation of late-life cognitive impairment by providing an objective measure for Alzheimer’s disease (AD) pathology. Here we present the results of the first clinical trial with [(18)F]AV-45 (Florbetapir F 18...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wong, Dean F., Rosenberg, Paul B., Zhou, Yun, Kumar, Anil, Raymont, Vanessa, Ravert, Hayden T., Dannals, Robert F., Nandi, Ayon, Brašić, James R., Ye, Weiguo, Hilton, John, Lyketsos, Constantine, Kung, Hank F., Joshi, Abhinay D., Skovronsky, Daniel M., Pontecorvo, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101877/
https://ncbi.nlm.nih.gov/pubmed/20501908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.109.069088
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars